Oxford BioTherapeutics at World ADC London 2027

Mar 8–11, 2027 London, UK ~700 attendees Website

Oxford BioTherapeutics takes part in 2 sessions at World ADC London 2027 in London. Its sessions cover how clinical outcomes should shape new ADC designs and how next-generation ADCs can become standard-of-care therapies.

OrganizationWorld ADC London 2027 Attendance
oxfordbiotherapeutics.com
Biotech
Oncology biotech discovering new cancer targets and developing antibody and ADC therapies, including the CD205-directed ADC OBT076.
Panel
Tue Mar 9
9:30am
CEO & ADC Pharma Leaders Think Tank: Solidifying Next Generation ADCs as Standard of Care Therapies
Plenary · with Iksuda Therapeutics, Araris Biotech, Boehringer Ingelheim
Clinical development
Workshop
Thu Mar 11
1:00pm
Leveraging Clinical Outcomes & Performance to Inform the Development of Novel ADC Design
Post-conference workshop for Clinical Lessons · with Iksuda Therapeutics
ADC discovery

Explore the full World ADC London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full World ADC London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Oxford BioTherapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction